Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca(2+) signalling

Serena Stadler, Huu Chi Nguyen, Helga Schachner, Daniela Milovanovic, Silvio Holzner, Stefan Brenner, Julia Eichsteininger, Mira Stadler, Daniel Senfter, Liselotte Krenn, Wolfgang M Schmidt, Nicole Huttary, Sigurd Krieger, Oskar Koperek, Zsuzsanna Bago-Horvath, Konstantin Alexander Brendel, Brigitte Marian, Oliver de Wever, Robert M Mader, Benedikt GiessriglWalter Jäger, Helmut Dolznig, Georg Krupitza

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Pages (from-to)1907-1921
    Number of pages15
    JournalCellular and Molecular Life Sciences
    Volume74
    Issue number10
    Early online date24 Dec 2016
    DOIs
    Publication statusPublished - May 2017

    Austrian Fields of Science 2012

    • 301209 Pharmacy

    Keywords

    • 3D invasion model
    • ACTIVATION
    • ARACHIDONIC-ACID
    • Arachidonic acid metabolite
    • CAMP PRODUCTION
    • ECM
    • ENDOTHELIAL-CELLS
    • EXPRESSION
    • IN-VITRO
    • INTRAVASATION
    • LIGHT-CHAIN KINASE
    • PHOSPHOLIPASE-C-EPSILON
    • RECEPTOR
    • Signal transduction
    • Tumour progression

    Fingerprint

    Dive into the research topics of 'Colon cancer cell-derived 12(S)-HETE induces the retraction of cancer-associated fibroblast via MLC2, RHO/ROCK and Ca(2+) signalling'. Together they form a unique fingerprint.

    Cite this